NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Scope & Guideline

Pioneering Research in Pharmacology Since 1969

Introduction

Welcome to your portal for understanding NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0028-1298
PublisherSPRINGER
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1969 to 2024
AbbreviationN-S ARCH PHARMACOL / Naunyn-Schmiedebergs Arch. Pharmacol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The Naunyn-Schmiedeberg's Archives of Pharmacology is a multidisciplinary journal focused on advancing the field of pharmacology through the publication of high-quality research articles. The journal covers a wide spectrum of topics related to pharmacological science, including drug discovery, mechanisms of action, pharmacodynamics, toxicology, and clinical applications.
  1. Pharmacological Mechanisms and Drug Action:
    Research that elucidates the pharmacological mechanisms of various compounds, including natural products and synthesized drugs, focusing on their effects on biological systems.
  2. Toxicology and Safety Assessments:
    Studies evaluating the toxicological properties of drugs and other substances, assessing their safety and potential adverse effects in various models.
  3. Clinical Pharmacology and Therapeutics:
    Investigations into the clinical applications of pharmacological agents, including efficacy, safety, and pharmacokinetics in human subjects.
  4. Innovative Drug Delivery Systems:
    Development and evaluation of new drug delivery systems, including nanoparticles and other advanced formulations to enhance therapeutic efficacy.
  5. Natural Products and Traditional Medicine:
    Exploration of the pharmacological properties of natural compounds and traditional medicines, including their potential therapeutic applications.
  6. Cancer Pharmacology and Chemotherapy:
    Research focused on the pharmacological treatment of cancer, including the mechanisms of action of chemotherapeutic agents and the development of drug resistance.
  7. Neuropharmacology and Behavioral Studies:
    Studies investigating the effects of drugs on the nervous system, including behavioral and neurochemical analyses in various animal models.
The journal has been increasingly focusing on several emerging themes that highlight the current trends in pharmacological research. These themes reflect the integration of modern technology, interdisciplinary approaches, and a growing emphasis on personalized medicine.
  1. Nanotechnology in Drug Delivery:
    A significant trend in recent publications is the exploration of nanotechnology for drug delivery systems, showcasing innovative methods to enhance the bioavailability and efficacy of therapeutic agents.
  2. Network Pharmacology and Systems Biology:
    An emerging theme involves the application of network pharmacology and systems biology approaches to understand complex interactions and mechanisms underlying drug actions and disease processes.
  3. Natural Products in Drug Discovery:
    There is a rising interest in the pharmacological potential of natural products, with studies focusing on their mechanisms of action and therapeutic applications in various diseases.
  4. Neuropharmacology and Mental Health:
    Research related to neuropharmacology, particularly concerning mental health disorders, has gained traction, reflecting a broader societal focus on mental health issues.
  5. Personalized Medicine Approaches:
    A growing emphasis on personalized medicine is evident, with studies exploring pharmacogenomics and tailored therapeutic strategies based on individual patient profiles.
  6. Impact of Gut Microbiome on Drug Metabolism:
    Research investigating the role of the gut microbiome in influencing drug metabolism and therapeutic responses is becoming increasingly relevant.

Declining or Waning

While the journal continues to publish a diverse range of topics, certain areas of research have shown a decline in frequency or prominence in recent publications. This shift may reflect changing priorities in the field of pharmacology or a transition towards more contemporary issues.
  1. Traditional Pharmacology:
    Research focusing solely on classical pharmacological studies without integrating modern approaches such as molecular biology or genomics appears to be less prevalent.
  2. Basic Mechanistic Studies:
    There seems to be a waning interest in purely mechanistic studies that do not translate into clinical applications or therapeutic advancements.
  3. Animal Models in Drug Testing:
    There is a noticeable decrease in studies utilizing traditional animal models for drug efficacy testing, as researchers increasingly turn to in vitro and humanized models.
  4. Drug Interactions in Polypharmacy:
    Research specifically addressing drug-drug interactions in polypharmacy contexts has become less frequent, possibly overshadowed by personalized medicine approaches.

Similar Journals

JOURNAL OF PHARMACY AND PHARMACOLOGY

Driving excellence in pharmacy and pharmacological research.
Publisher: OXFORD UNIV PRESSISSN: 0022-3573Frequency: 12 issues/year

Journal of Pharmacy and Pharmacology, published by Oxford University Press, is a prestigious academic journal dedicated to the advancement of knowledge in the fields of pharmaceutical sciences and pharmacology. With a strong heritage dating back to 1949, this journal maintains a robust influence, as evidenced by its ranking in the second quartile (Q2) across both Pharmaceutical Science and Pharmacology categories for 2023. The journal is accessible without an open access option, ensuring traditional academic engagement and providing valuable insights for researchers and professionals. It boasts an impressive Scopus ranking, with a percentile positioning of 72nd in Pharmaceutical Science and 67th in Pharmacology. Aimed at fostering innovative research and facilitating the exchange of cutting-edge scientific knowledge, the Journal of Pharmacy and Pharmacology serves as an essential resource for scientists, students, and healthcare professionals committed to enhancing therapeutic outcomes and advancing pharmaceutical innovations.

International Journal of Pharmacology

Advancing the Frontiers of Pharmacological Research
Publisher: ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINETISSN: 1811-7775Frequency: 8 issues/year

Welcome to the International Journal of Pharmacology, a key publication in the field of pharmacology, published by ASIAN NETWORK SCIENTIFIC INFORMATION (ANSINET). Since its inception in 2006, this journal has provided a vital platform for researchers and professionals to disseminate their findings and insights in pharmacology, toxicology, and pharmaceutics. Despite recent discontinuation in Scopus coverage, the journal's dedication to fostering scientific dialogue continues to attract contributions from esteemed scholars globally. With an **ISSN of 1811-7775** and **E-ISSN of 1812-5700**, the journal seeks to bridge the gap between laboratory research and clinical application, promoting a deeper understanding of drug actions and interactions. Although it operates under traditional access options, the relevance of its published studies to ongoing pharmacological research remains significant.

ANTI-CANCER DRUGS

Exploring New Horizons in Anti-Cancer Treatments
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0959-4973Frequency: 10 issues/year

ANTI-CANCER DRUGS is a leading journal in the domain of cancer research and pharmacology, published by Lippincott Williams & Wilkins. With its inception dating back to 1990 and ongoing publication through 2024, this journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements and discoveries in cancer therapeutics. Although classified in the Q3 quartile across relevant categories such as Cancer Research and Oncology, its growing impact is evidenced by its competitive Scopus rankings, positioned within the 30th to 52nd percentiles across various disciplines. The journal remains committed to promoting innovative research that can translate into effective anti-cancer strategies, providing valuable insights into drug development and applications. While it does not currently offer open access, the journal continues to attract a sophisticated readership, making it an essential platform for disseminating significant findings in the ever-evolving field of oncology.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Connecting scholars to tackle health challenges in the tropics.
Publisher: PHARMACOTHERAPY GROUPISSN: 1596-5996Frequency: 2 issues/year

Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.

SCIENTIA PHARMACEUTICA

Elevating the discourse in pharmacology and pharmaceutics.
Publisher: MDPIISSN: Frequency: 4 issues/year

SCIENTIA PHARMACEUTICA, published by MDPI in Switzerland, is a leading open access journal dedicated to advancing the field of pharmaceutical sciences since 2006. With a focus on pharmacology, toxicology, and pharmaceutics, this journal plays a pivotal role in disseminating high-quality research and innovative findings. It boasts an impressive impact factor and is ranked in the second quartile (Q2) for Pharmaceutical Science, signifying its influence within the academic community, aided by a Scopus ranking of 74 out of 183 journals in the same category. SCIENTIA PHARMACEUTICA invites original research articles, reviews, and notes that contribute to the understanding and development of pharmaceutical science, making it an essential resource for researchers, professionals, and students alike seeking to stay at the forefront of this continuously evolving field. For those interested in broadening their knowledge and sharing insights, the journal ensures wide accessibility, supporting the open access model for maximum outreach.

Advances in Pharmacological and Pharmaceutical Sciences

Advancing the Frontiers of Drug Discovery.
Publisher: HINDAWI LTDISSN: 2633-4682Frequency: 1 issue/year

Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Enhancing Understanding of Pharmacological Treatments and Toxicology
Publisher: WILEYISSN: 1742-7835Frequency: 12 issues/year

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, published by WILEY, serves as a vital resource in the fields of medicine, pharmacology, and toxicology. With an ISSN of 1742-7835 and E-ISSN 1742-7843, this journal has established a robust reputation, reflected in its Q2 classification across its categories in 2023. It aims to disseminate high-quality research and reviews that bridge the gap between basic scientific findings and clinical applications. Operating from the United States with an address at 111 RIVER ST, HOBOKEN 07030-5774, NJ, this journal focuses on the intersection of drug action and toxicity, making it an essential platform for researchers, healthcare professionals, and students. With a converged publication timeline from 2004 to 2024, BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY continues to make significant contributions to understanding pharmacological treatments and toxicological challenges. Open access options are available to broaden the reach and impact of its published work.

MOLECULAR PHARMACOLOGY

Unlocking Molecular Mechanisms for Better Therapeutics
Publisher: AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICSISSN: 0026-895XFrequency: 12 issues/year

MOLECULAR PHARMACOLOGY, published by the American Society for Pharmacology and Experimental Therapeutics, is an influential peer-reviewed journal dedicated to advancing the field of pharmacology through comprehensive research on molecular mechanisms of drug action. With an impressive historic convergence from 1965 to 2024, this journal plays a pivotal role in disseminating high-quality research, showcasing significant findings that impact both clinical and experimental pharmacology. Notably, it holds a distinguished Q1 ranking in Pharmacology and a Q2 ranking in Molecular Medicine as of 2023, reflecting its prominence in the academic community. Researchers and practitioners engaged in pharmacological studies will benefit from the journal’s focus on new therapeutic strategies, drug development, and the molecular basis of drug action. While MOLECULAR PHARMACOLOGY is not an open-access journal, it offers a wealth of knowledge behind a subscription model, ensuring that contributors and readers maintain a high standard of academic rigor. Address all inquiries to the editorial office located at 9650 Rockville Pike, Bethesda, MD 20814-3995, United States.

BRITISH JOURNAL OF PHARMACOLOGY

Exploring the frontiers of pharmacology and toxicology.
Publisher: WILEYISSN: 0007-1188Frequency: 24 issues/year

British Journal of Pharmacology is a premier, peer-reviewed journal published by Wiley, specializing in the dynamic field of pharmacology. With a robust impact factor, this journal ranks in the top quartile (Q1) for pharmacology according to the 2023 category rankings, emphasizing its significance and reputation among the global scientific community. As an essential resource for researchers, professionals, and students alike, the journal provides a platform for innovative research spanning foundational studies to clinical applications in pharmacology, toxicology, and pharmaceutics. Since its inception in 1966, the journal has consistently contributed to the advancement of pharmacological science, fostering a deeper understanding of drug action mechanisms and therapeutic advancements. Although primarily subscription-based, the British Journal of Pharmacology is committed to disseminating high-quality research that shapes the future of the field.

BMC Pharmacology & Toxicology

Empowering discoveries in drug interactions and safety.
Publisher: BMCISSN: Frequency: 1 issue/year

Welcome to BMC Pharmacology & Toxicology, a premier open-access journal dedicated to advancing the fields of pharmacology and toxicology. Published by BMC since 2012, this esteemed journal offers a platform for researchers, professionals, and students to disseminate cutting-edge research and innovative findings that explore the intricate interactions between drugs and biological systems. With its robust Q2 ranking in both general medicine and pharmacology categories for 2023, BMC Pharmacology & Toxicology is recognized for its significant contributions to the academic community, reflected in its strategic positioning within the 61st and 49th percentiles in Scopus rankings for related disciplines. The journal's commitment to open access ensures that vital research is accessible to a global audience, fostering collaboration and informed discussions. We invite you to engage with the latest studies, reviews, and innovative methodologies that shape the future of pharmacological and toxicological sciences.